News
S&P 500 financials kick off earnings season with 95% beating estimates. Highlights from JPMorgan, Morgan Stanley, Citigroup & ...
Pfizer Inc. (NYSE:PFE) hasn’t performed well in recent years, with its stock declining more than 26% over the past decade.
1d
Zacks Investment Research on MSNNetflix Q2 Earnings Beat on Squid Game Finale, 2025 Outlook RaisedNetflix NFLX reported second-quarter 2025 earnings of $7.19 per share, which beat the Zacks Consensus Estimate by 1.7%. The ...
1d
New York Giants On SI on MSNNew York Giants Interior Defensive Line Breakdown: Strength, Questions and 2025 OutlookStrength, Questions and 2025 Outlook ...
M Company (MMM) reports better-than-expected Q2 2025 results, raises full-year guidance, driven by growth in all business ...
Pfizer, in partnership with Bristol Myers Squibb, has launched a direct-to-patient sales strategy for Eliquis®, aiming to ...
Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...
American Express stock has been stable but unspectacular this year, staying in lockstep with the broader market. With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results